Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755312 · ClinicalTrials.gov registry record · NA
The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes
A NA study, sponsored by Purdue University.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01755312: Clinical Trial NA study, sponsored by Purdue University.
NCT01755312 is a NA study that was terminated before completion, run by Purdue University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01755312, a NA study, was terminated before completion, sponsored by Purdue University.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed
Interventions
- DEVICE Medication reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-01 |
| Phase | NA |
Why NCT01755312 stopped before completion
NCT01755312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Medication reminder is the first listed.
NCT01755312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01755312 about?
NCT01755312 is a clinical study titled "The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes". This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed
What is the current status of trial NCT01755312?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2013-06. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01755312?
The interventions under investigation include: Medication reminder (DEVICE).
Who is sponsoring clinical trial NCT01755312?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01755312's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia